Is Cerevel Therapeutics Holdings Inc (CERE) Stock at the Top of the Biotechnology Industry?

Tuesday, March 21, 2023 12:20 PM | InvestorsObserver Analysts

Mentioned in this article

Cerevel Therapeutics Holdings Inc (CERE) is around the top of the Biotechnology industry according to InvestorsObserver. CERE received an overall rating of 66, which means that it scores higher than 66 percent of all stocks. Cerevel Therapeutics Holdings Inc also achieved a score of 78 in the Biotechnology industry, putting it above 78 percent of Biotechnology stocks. Biotechnology is ranked 35 out of the 148 industries.

CERE has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on CERE!
See Full CERE Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Cerevel Therapeutics Holdings Inc Stock Today?

Cerevel Therapeutics Holdings Inc (CERE) stock is down -1.96% while the S&P 500 has risen 0.68% as of 12:17 PM on Tuesday, Mar 21. CERE has fallen -$0.48 from the previous closing price of $24.53 on volume of 325,099 shares. Over the past year the S&P 500 is lower by -10.82% while CERE has fallen -22.44%. CERE lost -$2.32 per share the over the last 12 months. Click Here to get the full Stock Report for Cerevel Therapeutics Holdings Inc stock.

Share this article:

Related Articles